Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Obesity 410Neoplasms 151Mucositis 128Sexual Dysfunction, Physiological 105Breast Neoplasms 105Polycystic Ovary Syndrome 98Overweight 98Dyspnea 62Constipation 57Motor Activity 54Head and Neck Neoplasms 47Prostatic Neoplasms 42Weight Loss 39Diabetes Mellitus 36Pain 34Colorectal Neoplasms 33Endometrial Neoplasms 29Stomatitis 28Opioid-Induced Constipation 28Lung Neoplasms 28Depression 26Diabetes Mellitus, Type 2 24Cardiovascular Diseases 23Obesity, Morbid 22Multiple Endocrine Neoplasia Type 1 22Insulin Resistance 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Anxiety Disorders 21Hypertension 19Sexual Dysfunctions, Psychological 18

Interventions

mirogabalin 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
CIPN × Other × Clear all
NCT06711978 2024-12-02

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

Pusan National University Yangsan Hospital

Phase NA Not yet recruiting
66 enrolled
BreastOther

CIPN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡